Rising longevity still poses a risk despite some schemes having their fingers burnt at successive valuations, Club Vita warns.
Longevity consultant Andrew Gaches told delegates: "Unpleasant surprises remain a real possibility at triennial valuations, especially if schemes don't monitor longevity between valuations." He added...
With pressures on health unlikely to abate in the near future, Aon's Guide to Risk Settlement analyses the cost of longevity reinsurance.
"The solvency deficit reported by our scheme actuary is much bigger than the company can afford. It's not worth us thinking about buyout now.. is it?"
Navigating the settlement market to find a solution that best meets an investor’s needs is a challenge that continues to plague the market
Concerns have been raised about making members more aware of risks to their defined benefit (DB) pensions, for fear of leading to panic and knee-jerk reactions.
The de-risking phenomenon is drying up long-term investment in younger generations as companies are forced to put more into defined benefit (DB) schemes, according to Ashok Gupta.